With the lower treatment costs achieved thanks to #biosimilars, we can re-invest in other health care services – like childcare, eldercare, mental health services, research and more. #GlobalBiosimilarsWeek
Biosimilars treatment costs for patients, government health programs and other payers, budget resources can be devoted to other health care initiatives. https://bit.ly/GlobalBiosimilarsWeek #GlobalBiosimilarsWeek
By lowering treatment costs, biosimilars can help fund the innovative new treatments needed by patients. https://bit.ly/GlobalBiosimilarsWeek #GlobalBiosimilarsWeek
The introduction of #biosimilars across the globe has expanded patient access to life- saving medicines and freed up important resources that can benefit other areas of healthcare. #GlobalBiosimilarsWeek
During #GlobalBiosimilarsWeek, we celebrate the many more patients who obtained access to the medicines they needed after biosimilar medicines became available. https://bit.ly/GlobalBiosimilarsWeek
Patients can have confidence in their #biosimilar medicines. Regulatory approval confirms no clinically meaningful differences expected in safety and efficacy between a biosimilar and the reference drug. #GlobalBiosimilarsWeek